Fortress Biotech Inc (FBIO)

01:29 AM

Equities Analysts Offer Predictions for FBIO Q1 Earnings - Defense World

01:29 AM

Mar 12, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Mar 12, 2025

Mar 12, 2025

Fortress Biotech (NASDAQ:FBIO) Receives “Buy” Rating from Roth Mkm - Defense World

Mar 12, 2025

Mar 11, 2025

Benign Growth For Fortress Biotech, Inc. (NASDAQ:FBIO) Underpins Its Share Price - Simply Wall St

Mar 11, 2025

Mar 10, 2025

CKPT Merger Alert: Checkpoint Shareholders Seeking Money Should Contact Julie & Holleman Regarding Sale to Sun Pharma - Longview News-Journal

Mar 10, 2025

Mar 10, 2025

Lake Street Downgrades Checkpoint Therapeutics to Hold From Buy, $4.10 Price Target - Marketscreener.com

Mar 10, 2025

Mar 10, 2025

Checkpoint (CKPT) Shares Skyrocket After A Takeover Agreement - Stocks Telegraph

Mar 10, 2025

Mar 10, 2025

Checkpoint Therapeutics Shares Leap Premarket on Takeover by Sun Pharma -March 10, 2025 at 06:24 am EDT - Marketscreener.com

Mar 10, 2025

Mar 10, 2025

Sun Pharma to Acquire Checkpoint Therapeutics - StockTitan

Mar 10, 2025

Mar 10, 2025

Checkpoint Therapeutics to Be Acquired by India's Sun Pharmaceutical -March 10, 2025 at 04:50 am EDT - Marketscreener.com

Mar 10, 2025

Mar 10, 2025

Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics for $355 million; shares edge higher - Mint

Mar 10, 2025

Mar 10, 2025

Sun Pharma to acquire US based onco-derma firm Checkpoint for $355 mn - Business Standard

Mar 10, 2025

Mar 10, 2025

Sun Pharma to acquire 100% stake in Nasdaq-listed Checkpoint Therapeutics - Business Standard

Mar 10, 2025

Mar 09, 2025

India's Sun Pharma to acquire Checkpoint Therapeutics for $355 million - Reuters.com

Mar 09, 2025

Mar 09, 2025

India's Sun Pharma to acquire Checkpoint Therapeutics for $355 million -March 09, 2025 at 11:49 pm EDT - Marketscreener.com

Mar 09, 2025

Mar 09, 2025

India’s Sun Pharma to buy Checkpoint Therapeutics for $355 mln By Investing.com - Investing.com Australia

Mar 09, 2025

Mar 09, 2025

Sun Pharma to acquire Checkpoint Therapeutics for Rs 3,000 crore - Business Upturn

Mar 09, 2025

Mar 05, 2025

Mustang Bio meets Nasdaq’s equity listing requirements By Investing.com - Investing.com South Africa

Mar 05, 2025

Mar 05, 2025

Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement - The Manila Times

Mar 05, 2025

Feb 28, 2025

Fortress Biotech, Inc. (NASDAQ:FBIOP) Short Interest Down 78.3% in February - Defense World

Feb 28, 2025

Feb 27, 2025

Mustang Bio Announces Sale of Fixed Assets and Exit of Facility - GlobeNewswire

Feb 27, 2025

Feb 27, 2025

Trading (FBIOP) With Integrated Risk Controls - Stock Traders Daily

Feb 27, 2025

Feb 18, 2025

FDA extends review of Fortress Biotech's CUTX-101 drug - MSN

Feb 18, 2025

Feb 17, 2025

Is Fortress Biotech Inc (NASDAQ: FBIO) Still Hot This Week? - Stocks Register

Feb 17, 2025

Feb 16, 2025

(FBIOP) On The My Stocks Page - Stock Traders Daily

Feb 16, 2025

Feb 14, 2025

Buying Buzz: Fortress Biotech Inc [FBIO] PRESIDENT, CEO & CHAIRMAN ROSENWALD LINDSAY A MD purchases 763,359 shares of the company – Knox Daily - Knox Daily

Feb 14, 2025

Feb 12, 2025

Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement - The Manila Times

Feb 12, 2025

Feb 11, 2025

Nasdaq Compliance Alert: Mustang Bio Clears Major Hurdle with $2.5M Equity Milestone - StockTitan

Feb 11, 2025

Feb 10, 2025

Mustang Bio Closes $8 Million Public Offering - citybiz

Feb 10, 2025

Feb 10, 2025

Mustang Bio Announces Closing of $8 Million Public Offering - GlobeNewswire

Feb 10, 2025

Feb 07, 2025

Mustang Bio sets terms for $8M public offering - MSN

Feb 07, 2025

Feb 07, 2025

Mustang Bio sets terms for $8M public offering By Investing.com - Investing.com Nigeria

Feb 07, 2025

Feb 06, 2025

Mustang Bio Announces Pricing of $8 Million Public Offering - The Manila Times

Feb 06, 2025

Feb 06, 2025

Mustang Bio Announces Pricing of $8 Million Public Offering - Benzinga

Feb 06, 2025

Feb 06, 2025

Capital Raise Alert: Mustang Bio Secures Fresh $8M Funding Through Strategic Share & Warrant Offering - StockTitan

Feb 06, 2025

Feb 05, 2025

Fortress Biotech (NASDAQ:FBIOP) Trading Up 0.3% – Still a Buy? - Defense World

Feb 05, 2025

Jan 31, 2025

Mustang Bio stock plunges to 52-week low of $4 - MSN

Jan 31, 2025

Jan 29, 2025

Triplex vaccine enters Phase 2 trial in stem cell donors - MSN

Jan 29, 2025

Jan 28, 2025

Fortress Biotech announces first patient dosed in Phase 2 trial of Triplex - Yahoo Finance

Jan 28, 2025

Jan 28, 2025

Fortress Biotech Announces First Patient Dosed in Phase 2 - GlobeNewswire

Jan 28, 2025

Jan 27, 2025

Fortress Biotech (FBIO) Announces First Patient Dosed in Phase 2 Clinical Trial of Triplex Vaccination - StreetInsider.com

Jan 27, 2025

Jan 25, 2025

(FBIOP) Investment Analysis - Stock Traders Daily

Jan 25, 2025

Jan 24, 2025

FBIOFortress Biotech, Inc. Latest Stock News & Market Updates - StockTitan

Jan 24, 2025

Jan 19, 2025

Fortress Biotech, Inc. (NASDAQ:FBIO) Sees Large Increase in Short Interest - MarketBeat

Jan 19, 2025

Jan 19, 2025

Fortress Biotech (NASDAQ: FBIO) Receives Notification of Extended FDA Target Action Date for CUTX-101 - Defense World

Jan 19, 2025

Jan 18, 2025

Boom Or Bust: What Are Fortress Biotech Inc’s (NASDAQ:FBIO) Future Prospects? - Marketing Sentinel

Jan 18, 2025

Jan 17, 2025

FDA extends review of Fortress Biotech's CUTX-101 drug By Investing.com - Investing.com Canada

Jan 17, 2025